TB-500 Mixing & Dosage Protocols

TB-500 (10 mg) — Research Dosage Guidance

Tissue Repair • Recovery • Performance Support

  • Reconstitution (Mixing)
  • Add 2 ml Bacteriostatic Water to the vial
  • Roll gently between palms (do not shake)
  • Store reconstituted vial in the refrigerator (2–8 °C)

Concentration Calculation

10 mg ÷ 2 ml = 5 mg/ml

Every 10 insulin units (0.1 ml) = 0.5 mg (500 mcg)

Core Dosage Guidelines

For injury repair, recovery, and performance-support research

Acute injury / post-surgical repair: 1–2 mg, 3× weekly

Maintenance / general wellbeing: 250–500 mcg, 2–3× weekly

Administration: Subcutaneous or intramuscular; if possible, administer near the affected area

Injection sites: Rotate regularly

Dose Conversion Table

Dose    Volume    Insulin Units

250 mcg    0.05 ml    5 units
500 mcg    0.10 ml    10 units
1 mg    0.20 ml    20 units
2 mg    0.40 ml    40 units

Reference: Every 10 units (0.1 ml) = 500 mcg TB-500

Targeted Research Protocols (Different Situations)
1.⁠ ⁠Acute Injury & Surgical Recovery

  • (Tendon/ligament tears, post-procedure healing)
  • Dose: 1–2 mg
  • Frequency: 3× weekly
  • Duration: 4–6 weeks
  • Notes: IM or SC near affected area when appropriate

2.⁠ ⁠Chronic Pain, Overuse & Inflammation

  • (Tendinopathy, repetitive strain, joint stress)
  • Dose: 500 mcg – 1 mg
  • Frequency: 2–3× weekly
  • Duration: 6–8 weeks
  • Notes: Consistent dosing preferred over higher spikes

3.⁠ ⁠Muscle Recovery & Athletic Performance

  • (Training load, micro-trauma recovery)
  • Dose: 1 mg
  • Frequency: 2× weekly
  • Timing: Post-training or rest days
  • Duration: 6–8 weeks

4.⁠ ⁠Soft-Tissue & Mobility Support

  • (Fascial health, flexibility, range of motion)
  • Dose: 500 mcg
  • Frequency: 2–3× weekly
  • Duration: 6 weeks
  • Notes: Often paired with physiotherapy models

5.⁠ ⁠Maintenance / Preventative Research

  • Dose: 250–500 mcg
  • Frequency: 2× weekly
  • Duration: Ongoing after recovery
  • Notes: Maintains tissue resilience with minimal exposure

Cycle Duration

  • Active recovery cycle: 4–8 weeks (based on severity)
  • Maintenance: 250–500 mcg, 2× weekly thereafter
  • Repeat cycles: May be repeated as required for research objectives

Key Research Benefits

  • Accelerates tissue repair and cellular migration
  • Supports tendon, ligament, and muscle recovery
  • Enhances flexibility and mobility
  • Assists recovery from strain and repetitive stress
  • Complements regenerative research stacks (e.g., BPC-157, GHK-Cu)

Important Notes

Always use sterile needles and alcohol swabs

Do not reuse or share needles

Store reconstituted solution at 2–8 °C

For research use only